Company intelligence / Profile preview

Direct Meds

Hallandale Beach, Florida, United States

Ownership: Private
Development stage: Other

Overview

Direct Meds is a specialty pharmacy and healthcare services provider that focuses on the management of complex, chronic conditions. The company provides specialized medication therapy, patient education, and support services for indications such as HIV/AIDS, Hepatitis C, oncology, and transplant medicine. By offering personalized care and coordinating with healthcare providers and insurers, Direct Meds aims to improve patient adherence and clinical outcomes. The company was acquired by CareMed Specialty Pharmacy in 2014, which was subsequently integrated into the PharMerica corporate structure.

Therapeutic areas: RheumatologyDermatologyInfectious DiseasesImmunologyOncology
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on Direct Meds.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Direct Meds.

Explore the full profile